AKTIS ONCOLOGY, INC.
Profile
Company Names
AKTIS ONCOLOGY, INC.
Addresses
17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA 02210
Phone Numbers
978-237-4380
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2020
State Incorporated:
DELAWARE
Total Amount Raised:
$175,000,000.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2024-09-20
$175,000,000.00
$175,000,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
TODD
FOLEY
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.
| ZALICUS INC.
| CELLADON CORP
| SELEXYS PHARMACEUTICALS CORP
| PROTEON THERAPEUTICS INC
| ICONIC THERAPEUTICS INC
| VALERITAS INC
| TETHEREX PHARMACEUTICALS CORP
| CLINICAL INK, INC.
| SEMMA THERAPEUTICS, INC.
| RHYTHM METABOLIC, INC.
| RHYTHM PHARMACEUTICALS, INC.
| ENTRADA THERAPEUTICS, INC.
| MOAT BIOTECHNOLOGY CORP
| CROSSBOW THERAPEUTICS, INC.
| FIREFLY BIO, INC.
| AKTIS ONCOLOGY, INC.
HELEN
S.
KIM
DIRECTOR
ANDREW
LEVIN
DIRECTOR
IMMUNETICS, INC.
| ARVINAS HOLDING COMPANY, LLC
| SYNTHORX, INC.
| CLEANBREAK, INC.
| CLEAR CREEK BIO, INC.
| IMBRIA PHARMACEUTICALS, INC.
| ELIEM THERAPEUTICS, INC.
| ATHENEN THERAPEUTICS, INC.
| ARCUATE THERAPEUTICS, INC.
| AEROVATE THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| CYTEK BIOSCIENCES, INC.
| METAGENOMI TECHNOLOGIES, LLC
| LUSARIS THERAPEUTICS, INC.
| SUPERLUMINAL MEDICINES, INC.
| NAVIGATOR MEDICINES, INC.
| AKTIS ONCOLOGY, INC.
| PAHR THERAPEUTICS, INC.
| LONESTAR MEDICINES, INC.
| SOLSTICE ONCOLOGY, INC.
| SLATE MEDICINES, INC.
| CLIMB BIO, INC.
OLEG
NODELMAN
DIRECTOR
BIOTECHNOLOGY VALUE FUND II LP
| BIOTECHNOLOGY VALUE FUND L P
| ECOR1 CAPITAL FUND, L.P.
| ECOR1 CAPITAL FUND QUALIFIED, L.P.
| ECOR1 VENTURE OPPORTUNITY FUND, LP
| ECOR1 VENTURE OPPORTUNITY OFFSHORE FUND, L.P.
| RECODE THERAPEUTICS, INC.
| SCORPION THERAPEUTICS, INC.
| AKTIS ONCOLOGY, INC.
| EPIKAST INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

